RESEARCH PROTECTION InfoMail's

 

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)

 

http://www.ahrp.org

Contact: Vera Hassner Sharav

212-595-8974

e-mail: veracare@ahrp.org

 

FYI

 

Eighteen month old, Daniella Rogers, died on May 3, 2002, two months after

undergoing a clinical trial of chemotherapy treatments at St. Louis

Children's Hospital.

 

When her parents, John and Oksana Rogers, learned that their baby daughter,

Daniella, had cancer, they knew she might die. But they hardly expected that

the medicine that was supposed to save her would instead take her life.

 

"It wasn't the cancer that killed her. It was the treatment," Oksana Rogers

said

 

The St. Louis Post Dispatch reports: "The chemotherapy drugs Daniella

received [ ] as part of a clinical trial caused the blood in the small

vessels of her liver to clot like curdled milk. Three other children died of

the same side effect before the study's sponsor, Children's Oncology Group

of Arcadia, Calif., and the National Cancer Institute temporarily suspended

the trial last year."

 

The federal Office of Human Research Protections (OHRP)has ruled that the

University of St. Louis

 medical school had not spelled out the risk of veno-occlusive disease of

the liver, a rare but well-known reaction to commonly used, toxic,

cancer-fighting drugs. [See

http://ohrp.osophs.dhhs.gov/detrm_letrs/YR03/jan03a.pdf ]

 

In this trial, the treatment-induced disease occurred in about 1 out of 20

patients.

Four of the 360 children enrolled died of it.

 

However, an investigation by the FDA found "no significant deviations."

The disagreement between the inspectors of two federal agencies about what

constitutes

ethical / legal violations of informed consent illustrates a lack of

consistent standards--even between two federal oversight agencies.

 

"Daniella's case is one of the latest to raise questions about the massive

clinical research industry, and to provoke debate about how far researchers

must go to make sure subjects understand the risks." The parents say they

were not told about the risks or the other deaths.

 

The circumstances of Daniella's death highlight once again, disturbing

questions:

How safe is it to enroll a child in clinical research?

What constitutes informed consent?

Where can a family turn for help?

What compensation is there if research subjects are harmed?

Who is accountable if ethical standards are violated and death results?

 

The Post Dispatch correctly reports that OHRP's finding "carries no

sanctions or fines."

The parents' public complaints led Washington University to change its

informed consent for the remaining participants in the cancer trial to

better reflect the actual risks.

 

The Post-Dispatch reports that "Washington University wouldn't allow

[reporters] to interview its doctors about Daniella's case because the

Rogers family has threatened to sue. However, the university released

several statements and documents that defend its actions."

 

According to the Post-Dispatch, FDA's chief of human subject protection

division, Dr. David Lepay, credited the research enterprise claiming that

his agency's inspectors "find far fewer problems now than they did 25 years

ago, when perhaps 20 percent of trials failed to meet key regulations. Now,

the number of violators is around 2 percent."

 

Given the risks in clinical trials are often involve matters of life or

death, it is hard to understand FDA's disregard for violations of federal

disclosure requirements which are necessary for valid, informed consent.  If

the agency dismisses violations of informed consent as "not significant

deviations," it is difficult to know what violations FDA's inspectors do

consider "significant." Dr. Lepay's optimistic calculation --2 percent

violations--is at best pulled out of a hat.

 

Full article with pictures of Daniella [whose age was incorrectly stated in

the article]

and her parents are online at:

 

 

 

 

Death prompts scrutiny of research risks

By Sara Shipley Of the Post-Dispatch

02/15/2003 12:39 PM

________________________________________________________________________

 Thu, 14 Nov 2002

Dying for a Cure: Pediatric Cancer Trial Undisclosed facts - NBC, Chicago

 

How can parents protect their children from harmful medical experiments if the facts are withheld from them? So far, Congress has enacted no law to protect children from experiments that disregard their life-safety in clinical trials.

An investigative news report aired last night by WMAQ-TV, an NBC owned station in Chicago, focused on a government sponsored pediatric cancer trial-- COG D9803. The station's investigative team (unit 5) uncovered documents revealing previously undisclosed deaths of 4 children, and 16 cases of a life-threatening side effect of the drugs used to treat the cancer-- veno-occlusive disease or VOD, (liver failure).

In all, 300 children had been enrolled in the trial at 250 locations in the US and abroad. See list:
http://www.nbc5.com/news/1781498/detail.html

NBC Unit-t reported that physicians received a $2,000 per case reimbursement for enrolling children in the trial, COG D9803.

On July 22, 2002, the Station filed a Freedom of Information request with the National Institutes of Health asking for information on the federally-funded study, specifics of adverse-event reports, and the number of deaths related to VOD. Less than a month later, the trial was suspended and the Office for Human Research Protections said it was beginning its own investigation.

Among those interviewed were the parents of two child casualties: twenty month old, Daniella Rogers, who died of VOD on On May 3, 2002, http://www.daniellarogers.org/ and the parents of three and a half year old Travis Whitman, who died October 21, 2001. http://www.traviswhitman.com/

The parents claim they were never warned about VOD--even though it is a life-threatening risk. Nor, they claim, were they told that children enrolled earlier had died in the trial.

 

 

John and Oksana Rogers
contact@daniellarogers.org

 


Google


Search WWW

Search daniellarogers.org
Search daniellarogers.net


More Links To Daniella on the Web.

Research Subjects News MSN

Childhood Cancer Resources

Child Organizations / Mental

Pediatric Cancer - Rhabdomyosarcoma

WEB DIRECTORY SITES - ABOUT Chemotherapy

Daniella's Hometown AOL page.

Daniella's MSN Site. (Rhabdo Kids)

Johnny & Janie Rogers Press Release (Daniella's Grandparents)

 

[ Previous 5 Sites | Skip Previous | Previous | Next ]

This RingSurf Childhood Cancer Net Ring
owned by Daniella Rogers.

[ Skip Next | Next 5 Sites | Random Site | List Sites ]

 



 

Site built and maintained by AlphaPhase.com

FAIR USE NOTICE: This website may contain copyrighted (© ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior general interest in receiving similar information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml If you wish to use copyrighted material for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.